SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000831547-21-000029
Filing Date
2021-04-30
Accepted
2021-04-30 16:11:30
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 13D casipharma-schedule13dxapr.htm SC 13D/A 121289
2 image_31.jpg GRAPHIC 328
3 image_51.jpg GRAPHIC 233
4 image_81.jpg GRAPHIC 153
5 image_91.jpg GRAPHIC 154
  Complete submission text file 0000831547-21-000029.txt   124809
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filed by) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 21878087
SIC: 2836 Biological Products, (No Diagnostic Substances)